It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NEOG’s FA Score shows that 1 FA rating(s) are green whilePRG’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NEOG’s TA Score shows that 5 TA indicator(s) are bullish while PRG’s TA Score has 6 bullish TA indicator(s).
NEOG (@Medical Specialties) experienced а +0.36% price change this week, while PRG (@Finance/Rental/Leasing) price change was +3.72% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.23%. For the same industry, the average monthly price growth was +15.69%, and the average quarterly price growth was +7.60%.
The average weekly price growth across all stocks in the @Finance/Rental/Leasing industry was +5.59%. For the same industry, the average monthly price growth was -2.64%, and the average quarterly price growth was +11.50%.
NEOG is expected to report earnings on Sep 30, 2025.
PRG is expected to report earnings on Oct 22, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Finance/Rental/Leasing (+5.59% weekly)A leasing company (e.g. United Rentals, Inc. ) is typically the legal owner of the asset for the duration of the lease, while the lessee has operating control over the asset while also having some share of the economic risks and returns from the change in the valuation of the underlying asset. Per capita disposable income and corporate earnings or cash flow could be some of the critical metrics for this business – the higher the values of these metrics, the potentially greater ability of consumers/businesses to afford apartments/office spaces for rent. Other finance companies include credit/debit card payment processing companies (e.g. Visa Inc. and Mastercard), private label credit cards providers (e.g. Synchrony Financial) and automobile finance companies (e.g. Credit Acceptance Corporation).
NEOG | PRG | NEOG / PRG | |
Capitalization | 1.22B | 1.37B | 89% |
EBITDA | -935.82M | 1.9B | -49% |
Gain YTD | -53.624 | -17.147 | 313% |
P/E Ratio | 865.00 | 6.84 | 12,640% |
Revenue | 895M | 2.52B | 36% |
Total Cash | 129M | 83.3M | 155% |
Total Debt | 894M | 603M | 148% |
NEOG | PRG | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 95 Overvalued | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 33 | |
PRICE GROWTH RATING 1..100 | 65 | 48 | |
P/E GROWTH RATING 1..100 | 3 | 97 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PRG's Valuation (27) in the null industry is significantly better than the same rating for NEOG (95) in the Medical Specialties industry. This means that PRG’s stock grew significantly faster than NEOG’s over the last 12 months.
PRG's Profit vs Risk Rating (100) in the null industry is in the same range as NEOG (100) in the Medical Specialties industry. This means that PRG’s stock grew similarly to NEOG’s over the last 12 months.
PRG's SMR Rating (33) in the null industry is somewhat better than the same rating for NEOG (97) in the Medical Specialties industry. This means that PRG’s stock grew somewhat faster than NEOG’s over the last 12 months.
PRG's Price Growth Rating (48) in the null industry is in the same range as NEOG (65) in the Medical Specialties industry. This means that PRG’s stock grew similarly to NEOG’s over the last 12 months.
NEOG's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for PRG (97) in the null industry. This means that NEOG’s stock grew significantly faster than PRG’s over the last 12 months.
NEOG | PRG | |
---|---|---|
RSI ODDS (%) | 2 days ago80% | 2 days ago73% |
Stochastic ODDS (%) | 2 days ago75% | 2 days ago73% |
Momentum ODDS (%) | 2 days ago59% | 2 days ago73% |
MACD ODDS (%) | 2 days ago61% | 2 days ago67% |
TrendWeek ODDS (%) | 2 days ago63% | 2 days ago71% |
TrendMonth ODDS (%) | 2 days ago63% | 2 days ago72% |
Advances ODDS (%) | 6 days ago67% | 6 days ago68% |
Declines ODDS (%) | 13 days ago78% | 2 days ago75% |
BollingerBands ODDS (%) | N/A | 2 days ago67% |
Aroon ODDS (%) | 2 days ago81% | 2 days ago83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PXWEX | 35.45 | 0.13 | +0.37% |
Impax Ellevate Global Women's Ldr Inv | |||
BWLIX | 25.31 | 0.06 | +0.24% |
American Beacon Man Lg Cp Value Inv | |||
LADQX | 20.89 | N/A | N/A |
Lord Abbett Developing Growth R2 | |||
HSWRX | 20.99 | N/A | N/A |
Hartford Schroders International Stk R3 | |||
MRIEX | 14.02 | -0.03 | -0.21% |
Meridian Hedged Equity Investor |
A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then RVTY could also see price increases.
Ticker / NAME | Correlation To NEOG | 1D Price Change % | ||
---|---|---|---|---|
NEOG | 100% | +0.54% | ||
RVTY - NEOG | 42% Loosely correlated | -0.99% | ||
IQV - NEOG | 40% Loosely correlated | -0.14% | ||
SHC - NEOG | 39% Loosely correlated | +0.06% | ||
RDNT - NEOG | 38% Loosely correlated | +1.41% | ||
QTRX - NEOG | 38% Loosely correlated | +0.43% | ||
More |